Effect of drug-targeting nebulization on lung delivery
Arch Bronconeumol. 2014 Nov;50(11):500-1.
doi: 10.1016/j.arbres.2013.10.014.
Epub 2013 Dec 29.
[Article in
English,
Spanish]
Affiliations
- 1 Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Pneumologie, ORL & Dermatologie, Université Catholique de Louvain, Bruselas, Bélgica; Service de Pneumologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruselas, Bélgica. Electronic address: [email protected].
- 2 Department of Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruselas, Bélgica; Department of Pediatry, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruselas, Bélgica.
- 3 Louvain Drug Research Institute, Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruselas, Bélgica.
- 4 Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Pneumologie, ORL & Dermatologie, Université Catholique de Louvain, Bruselas, Bélgica; Service de Pneumologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruselas, Bélgica.
No abstract available
Publication types
-
Comparative Study
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Administration, Inhalation
-
Adult
-
Aerosols
-
Albuterol / administration & dosage*
-
Albuterol / pharmacokinetics
-
Albuterol / urine
-
Amikacin / administration & dosage
-
Anthropometry
-
Anti-Asthmatic Agents / administration & dosage*
-
Anti-Asthmatic Agents / pharmacokinetics
-
Anti-Asthmatic Agents / urine
-
Biological Availability
-
Charcoal / administration & dosage
-
Equipment Design
-
Humans
-
Lung*
-
Male
-
Nebulizers and Vaporizers*
-
Spirometry
-
Young Adult
Substances
-
Aerosols
-
Anti-Asthmatic Agents
-
Charcoal
-
Amikacin
-
Albuterol
Associated data
-
ClinicalTrials.gov/NCT01913184